Development and Clinical Validation of Ketogen-based Therapeutic Diet

Not open yet.

Development and Clinical Validation of Ketogen-based Therapeutic Diet for Pancreaticobiliary Cancer Patients

Eligibility

Ages Eligible for Study: 19 Years to 80 Years (Adult, Senior)
Genders Eligible for Study: Both
Accepts Healthy Volunteers: No
Criteria
Inclusion Criteria:

Adult (age more than 19)
Pancreaticobiliary cancer patient who is scheduled pancreaticoduodenectomy or distal pancreatectomy
Pancreatic cancer / Duodenal cancer / Distal bile duct cancer / Ampulla of Vater cancer
Exclusion Criteria:

Patient who denied clinical trial
Diabetes Mellitus(DM) patient with DM complication
Hyperlipidemia patient with vascular co-morbidity
Impaired renal function or renal failure (GFP<90%)
Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT02964806

Locations
Korea, Republic of
Severance Hospital Not yet recruiting
Seoul, Korea, Republic of, 120-752
Contact: Chang Moo Kang, MD 82-2-2228-2100 cmkang@yuhs.ac
Sponsors and Collaborators
Yonsei University
More Information

Responsible Party: Yonsei University
ClinicalTrials.gov Identifier: NCT02964806 History of Changes
Other Study ID Numbers: 4-2016-0799
Study First Received: November 13, 2016
Last Updated: November 13, 2016
Health Authority: South Korea: Institutional Review Board
Individual Participant Data
Plan to Share IPD: No

ClinicalTrials.gov processed this record on November 17, 2016